IN THIS ISSUE

Charlotte Huff

Mark Preston, MD

Experts are rethinking the routine cancer screen. In the future, screening recommendations may be tailored, risk-stratified, and based on our genes.
Richard Mark Kirkner

Bradley C. Leibovich, MD
Mayo Clinic

Patients and doctors are fighting the urge to rush in and treat cancer right away. Insurers must walk a fine line.
Q&A
Interview by Peter Wehrwein

Vinay Prasad, MD

The intrepid young oncologist’s criticism of cancer screening and surrogate endpoints has stirred up controversy. He says he just wants drugmakers, others to meet high standards of evidence.
Vanessa Pawlak

Vanessa Pawlak
Ernst & Young

Success in the Medicare Stars ratings system requires a culture that looks beyond short-term success to ensure long-term survival.
Legislation & Regulation: Campaign 2016
Richard Mark Kirkner
The fate of the health care reform law will be determined by the outcome of a joyless election.
Peter Wehrwein
Costs Cast Shadow on Optimism About Treatment
Tomorrow’s Medicine
Thomas Morrow, MD
Carbon fiber is more flexible than metal, so it may help fractured bones heal faster. Carbon fiber hardware may also have an application in oncology.
Viewpoint
Zachary Hafner
He has other serious health problems and needs a clinician to quarterback the care for all his conditions—not just the cancer.
News & Commentary
Frank Diamond
News & Commentary
Frank Diamond
News & Commentary
Frank Diamond